Melanoma prognostic factors found in the dermatopathology report

Balzi, 1998, Skin melanoma in Italy: a population-based study on survival and prognostic factors, Eur J Cancer, 34, 699, 10.1016/S0959-8049(97)10119-8 Lindholm, 2004, Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors, Cancer, 101, 2067, 10.1002/cncr.20602 Austin, 1994, Age as a prognostic factor in the malignant melanoma population, Ann Surg Oncol, 1, 487, 10.1007/BF02303614 Chao, 2004, Correlation between prognostic factors and increasing age in melanoma, Ann Surg Oncol, 11, 259, 10.1245/ASO.2004.04.015 Ferrari, 2005, Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution, Pediatrics, 115, 649, 10.1542/peds.2004-0471 Sander, 1999, Cutaneous malignant melanoma in Swedish children and teenagers 1973-1992: a clinico-pathological study of 130 cases, Int J Cancer, 80, 646, 10.1002/(SICI)1097-0215(19990301)80:5<646::AID-IJC2>3.0.CO;2-H Reintgen, 1989, Juvenile malignant melanoma, Surg Gynecol Obstet, 168, 249 Cochran, 2000, Individualized prognosis for melanoma patients, Hum Pathol, 31, 327, 10.1016/S0046-8177(00)80246-4 Garbe, 1995, Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients, Cancer, 75, 2484, 10.1002/1097-0142(19950515)75:10<2484::AID-CNCR2820751014>3.0.CO;2-U Karakousis, 1995, Prognostic parameters in localised melanoma: gender versus anatomical location, Eur J Cancer, 31A, 320, 10.1016/0959-8049(94)00458-H Levi, 1998, Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland, Int J Cancer, 78, 315, 10.1002/(SICI)1097-0215(19981029)78:3<315::AID-IJC10>3.0.CO;2-5 Francken, 2004, The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up, Ann Surg Oncol, 11, 426, 10.1245/ASO.2004.07.014 Masback, 2001, Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review, Melanoma Res, 11, 435, 10.1097/00008390-200110000-00001 Ilmonen, 2002, Prognosis of primary melanoma, Scand J Surg, 91, 166, 10.1177/145749690209100206 Hsueh, 1999, Survival of patients with melanoma of the lower extremity decreases with distance from the trunk, Cancer, 85, 383, 10.1002/(SICI)1097-0142(19990115)85:2<383::AID-CNCR16>3.0.CO;2-3 Talley, 1998, Clinical outcomes of localized melanoma of the foot: a case-control study, J Clin Epidemiol, 51, 853, 10.1016/S0895-4356(98)00071-7 Barnes, 1994, Melanoma of the foot, J Bone Joint Surg Am, 76, 892, 10.2106/00004623-199406000-00013 Gillgren, 2000, A prospective population-based study of cutaneous malignant melanoma of the head and neck, Laryngoscope, 110, 1498, 10.1097/00005537-200009000-00017 Wanebo, 1988, Prognostic factors in head and neck melanoma. Effect of lesion location, Cancer, 62, 831, 10.1002/1097-0142(19880815)62:4<831::AID-CNCR2820620432>3.0.CO;2-X Lachiewicz, 2008, Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program, Arch Dermatol, 144, 515, 10.1001/archderm.144.4.515 Leong, 2006, Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients, Arch Otolaryngol Head Neck Surg, 132, 370, 10.1001/archotol.132.4.370 Benmeir, 1995, Melanoma of the scalp: the invisible killer, Plast Reconstr Surg, 95, 496, 10.1097/00006534-199503000-00009 Shumate, 1991, The prognostic implications of location for scalp melanoma, Am J Surg, 162, 315, 10.1016/0002-9610(91)90139-5 Nagore, 2005, Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis, Melanoma Res, 15, 169, 10.1097/00008390-200506000-00005 Law, 1994, Evaluation of the prognostic significance of the site of origin of cutaneous melanoma, Am Surg, 60, 362 Hoersch, 2006, Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma, Br J Dermatol, 155, 771, 10.1111/j.1365-2133.2006.07455.x Gillgren, 2005, Effect of primary site on prognosis in patients with cutaneous malignant melanoma. A study using a new model to analyse anatomical locations, Melanoma Res, 15, 125, 10.1097/00008390-200504000-00007 MacKie, 1997, Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group, BMJ, 315, 1117, 10.1136/bmj.315.7116.1117 Gimotty, 2004, Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging, J Clin Oncol, 22, 3668, 10.1200/JCO.2004.12.015 Leiter, 2004, Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society, J Clin Oncol, 22, 3660, 10.1200/JCO.2004.03.074 McKinnon, 2003, Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit, Cancer, 98, 1223, 10.1002/cncr.11624 Zalaudek, 2003, Local recurrence in melanoma in situ: influence of sex, age, site of involvement and therapeutic modalities, Br J Dermatol, 148, 703, 10.1046/j.1365-2133.2003.05155.x Breslow, 1970, Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma, Ann Surg, 172, 902, 10.1097/00000658-197011000-00017 Crowson, 2006, Prognosticators of melanoma, the melanoma report, and the sentinel lymph node, Mod Pathol, 19, S71, 10.1038/modpathol.3800517 Breslow, 1975, Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma, Ann Surg, 182, 572, 10.1097/00000658-197511000-00007 Barnhill, 1996, Predicting five-year outcome for patients with cutaneous melanoma in a population-based study, Cancer, 78, 427, 10.1002/(SICI)1097-0142(19960801)78:3<427::AID-CNCR8>3.0.CO;2-G Rousseau, 2003, Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients, Ann Surg Oncol, 10, 569, 10.1245/ASO.2003.09.016 Balch, 2001, Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system, J Clin Oncol, 19, 3622, 10.1200/JCO.2001.19.16.3622 Balch, 1978, A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods, Ann Surg, 188, 732, 10.1097/00000658-197812000-00004 McGovern, 1979, Prognostic significance of the histological features of malignant melanoma, Histopathology, 3, 385, 10.1111/j.1365-2559.1979.tb03020.x Day, 1981, A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease, Surgery, 89, 599 Day, 1981, A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease, Am J Surg, 142, 247, 10.1016/0002-9610(81)90286-5 Van Der Esch, 1981, Stage I melanoma of the skin: evaluation of prognosis according to histologic characteristics, Cancer, 48, 1668, 10.1002/1097-0142(19811001)48:7<1668::AID-CNCR2820480732>3.0.CO;2-9 Drzewiecki, 1982, Survival with malignant melanoma: a regression analysis of prognostic factors, Cancer, 49, 2414, 10.1002/1097-0142(19820601)49:11<2414::AID-CNCR2820491132>3.0.CO;2-V Prade, 1982, Malignant melanoma of the skin: prognostic factors derived from a multifactorial analysis of 239 cases, Am J Dermatopathol, 4, 411, 10.1097/00000372-198210000-00005 Day, 1982, Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51-3.39 mm). A conceptual model for tumor growth and metastasis, Ann Surg, 195, 35, 10.1097/00000658-198201001-00006 Kuehnl-Petzoldt, 1983, Prognostic groups of patients with stage I melanoma, Arch Dermatol, 119, 816, 10.1001/archderm.119.10.816 Balch, 1982, A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia, Ann Surg, 196, 677, 10.1097/00000658-198212001-00011 Urist, 1984, Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment, Ann Surg, 200, 769, 10.1097/00000658-198412000-00017 Cascinelli, 1985, Prognostic factors for stage I melanoma of the skin: a review, Stat Med, 4, 265, 10.1002/sim.4780040305 Shaw, 1985, Prognostic histopathological factors in malignant melanoma, Pathology, 17, 271, 10.3109/00313028509063766 Sondergaard, 1985, Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. A multivariate regression analysis, Virchows Arch A Pathol Anat Histopathol, 406, 179, 10.1007/BF00737084 Meyskens, 1988, Cutaneous malignant melanoma (Arizona Cancer Center experience). I. Natural history and prognostic factors influencing survival in patients with stage I disease, Cancer, 62, 1207, 10.1002/1097-0142(19880915)62:6<1207::AID-CNCR2820620628>3.0.CO;2-A Ronan, 1988, Histologic prognostic indicators in cutaneous malignant melanoma, Semin Oncol, 15, 558 Clark, 1989, Model predicting survival in stage I melanoma based on tumor progression, J Natl Cancer Inst, 81, 1893, 10.1093/jnci/81.24.1893 Vollmer, 1989, Malignant melanoma. A multivariate analysis of prognostic factors, Pathol Annu, 24, 383 Worth, 1989, Pathologic prognostic factors for cutaneous malignant melanoma: the Western Canada Melanoma Study, Int J Cancer, 43, 370, 10.1002/ijc.2910430303 Heenan, 1991, Survival among patients with clinical stage I cutaneous malignant melanoma diagnosed in Western Australia in 1975/1976 and 1980/1981, Cancer, 68, 2079, 10.1002/1097-0142(19911101)68:9<2079::AID-CNCR2820680940>3.0.CO;2-7 Haffner, 1992, The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients, Br J Cancer, 66, 856, 10.1038/bjc.1992.373 Soong, 1992, Predicting survival and recurrence in localized melanoma: a multivariate approach, World J Surg, 16, 191, 10.1007/BF02071520 Straume, 1996, Independent prognostic importance of vascular invasion in nodular melanomas, Cancer, 78, 1211, 10.1002/(SICI)1097-0142(19960915)78:6<1211::AID-CNCR7>3.0.CO;2-C Sahin, 1997, Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model, Cancer, 80, 1426, 10.1002/(SICI)1097-0142(19971015)80:8<1426::AID-CNCR9>3.0.CO;2-C Soong, 1998, Factors affecting survival following local, regional, or distant recurrence from localized melanoma, J Surg Oncol, 67, 228, 10.1002/(SICI)1096-9098(199804)67:4<228::AID-JSO4>3.0.CO;2-A Gershenwald, 1999, Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients, J Clin Oncol, 17, 976, 10.1200/JCO.1999.17.3.976 Haddad, 1999, The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion, Ann Surg Oncol, 6, 144, 10.1007/s10434-999-0144-y Balch, 2000, Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial, Ann Surg Oncol, 7, 87, 10.1007/s10434-000-0087-9 Wagner, 2000, Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma, Cancer, 89, 453, 10.1002/1097-0142(20000715)89:2<453::AID-CNCR34>3.0.CO;2-V Zettersten, 2003, Prognostic factors in primary cutaneous melanoma, Surg Clin North Am, 83, 61, 10.1016/S0039-6109(02)00094-4 Balch, 2001, Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma, J Clin Oncol, 19, 3635, 10.1200/JCO.2001.19.16.3635 Karakousis, 1989, Tumor thickness and prognosis in clinical stage I malignant melanoma, Cancer, 64, 1432, 10.1002/1097-0142(19891001)64:7<1432::AID-CNCR2820640712>3.0.CO;2-M Slingluff, 1988, Lethal “thin” malignant melanoma. Identifying patients at risk, Ann Surg, 208, 150, 10.1097/00000658-198808000-00004 Clark, 1969, The histogenesis and biologic behavior of primary human malignant melanomas of the skin, Cancer Res, 29, 705 Morton, 1993, Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness, Cancer, 71, 3737, 10.1002/1097-0142(19930601)71:11<3737::AID-CNCR2820711143>3.0.CO;2-7 Thorn, 1996, Predictors of late mortality in cutaneous malignant melanoma-a population-based study in Sweden, Int J Cancer, 67, 38, 10.1002/(SICI)1097-0215(19960703)67:1<38::AID-IJC9>3.0.CO;2-0 Marghoob, 2000, Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging, Cancer, 88, 589, 10.1002/(SICI)1097-0142(20000201)88:3<589::AID-CNCR15>3.3.CO;2-9 Buttner, 1995, Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification, Cancer, 75, 2499, 10.1002/1097-0142(19950515)75:10<2499::AID-CNCR2820751016>3.0.CO;2-8 Buzaid, 1997, Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system, J Clin Oncol, 15, 1039, 10.1200/JCO.1997.15.3.1039 Slingluff, 1992, “Thin” malignant melanoma: risk factors and clinical management, Ann Plast Surg, 28, 89, 10.1097/00000637-199201000-00023 Pontikes, 1993, Influence of level and depth on recurrence rate in thin melanomas, Am J Surg, 165, 225, 10.1016/S0002-9610(05)80514-8 Smolle, 1998, Automated measurement of melanoma cross-sectional area, Am J Dermatopathol, 20, 155, 10.1097/00000372-199804000-00009 Temple, 1998, Histologic staging in malignant melanoma: cross-sectional area revisited, J Surg Oncol, 69, 83, 10.1002/(SICI)1096-9098(199810)69:2<83::AID-JSO7>3.0.CO;2-E Friedman, 1991, Volume of malignant melanoma is superior to thickness as a prognostic indicator. Preliminary observation, Dermatol Clin, 9, 643, 10.1016/S0733-8635(18)30368-1 Gebhart, 1984, Computer-assisted volumetric analysis of cutaneous malignant melanomas, Am J Dermatopathol, 6, 93 Rongioletti, 2005, Unusual histological variants of cutaneous malignant melanoma with some clinical and possible prognostic correlations, J Cutan Pathol, 32, 589, 10.1111/j.0303-6987.2005.00418.x Larsen, 1979, A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 4. The relation of cross-sectional profile, level of invasion, ulceration and vascular invasion to tumour type and prognosis, Acta Pathol Microbiol Scand [A], 87A, 131 Siminovitch, 1980, Exophytic (pedunculated) malignant melanoma-Cleveland Clinic experience, Ann Plast Surg, 5, 432, 10.1097/00000637-198012000-00004 Manci, 1981, Polypoid melanoma, a virulent variant of the nodular growth pattern, Am J Clin Pathol, 75, 810, 10.1093/ajcp/75.6.810 Kuehnl-Petzoldt, 1982, Verrucous-keratotic variations of malignant melanoma: a clinicopathological study, Am J Dermatopathol, 4, 403 Beardmore, 1970, Malignant melanoma in Queensland: pathology of 105 fatal cutaneous melanomas, Pathology, 2, 277, 10.3109/00313027009077142 Liestol, 1982, A Retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 8. The Relative prognostic value of various clinical and histological features evaluated by Cox’s regression model, Acta Pathol Microbiol Immunol Scand [A], 90, 449 Corona, 1994, Survival and prognostic factors in patients with localised cutaneous melanoma observed between 1980 and 1991 at the Istituto Dermopatico dell’Immacolata in Rome, Italy, Eur J Cancer, 30A, 333, 10.1016/0959-8049(94)90252-6 Heaton, 1998, Surgical margins and prognostic factors in patients with thick (>4mm) primary melanoma, Ann Surg Oncol, 5, 322, 10.1007/BF02303495 Berdeaux, 1989, Cutaneous malignant melanoma. II. The natural history and prognostic factors influencing the development of stage II disease, Cancer, 63, 1430, 10.1002/1097-0142(19890401)63:7<1430::AID-CNCR2820630733>3.0.CO;2-G Retsas, 2002, Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients, Eur J Cancer, 38, 511, 10.1016/S0959-8049(01)00394-X Gordon, 1991, Poor prognosis for malignant melanoma in Northern Ireland: a multivariate analysis, Br J Cancer, 63, 283, 10.1038/bjc.1991.66 Lassau, 2002, Prognostic value of angiogenesis evaluated with high-frequency and color Doppler sonography for preoperative assessment of melanomas, AJR Am J Roentgenol, 178, 1547, 10.2214/ajr.178.6.1781547 Masback, 1997, Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations, Cancer, 79, 275, 10.1002/(SICI)1097-0142(19970115)79:2<275::AID-CNCR11>3.0.CO;2-Y Balch, 1980, The prognostic significance of ulceration of cutaneous melanoma, Cancer, 45, 3012, 10.1002/1097-0142(19800615)45:12<3012::AID-CNCR2820451223>3.0.CO;2-O Kim, 1999, Prognosis of thick cutaneous melanoma, J Am Coll Surg, 188, 241, 10.1016/S1072-7515(98)00296-8 Zettersten, 2002, Prognostic factors in patients with thick cutaneous melanoma (>4 mm), Cancer, 94, 1049, 10.1002/cncr.10326 Otto, 1999, Prognostic classification of malignant melanomas by combining clinical, histological, and immunohistochemical parameters, Oncology, 56, 208, 10.1159/000011967 Cuellar, 2004, Small cell melanoma and ulceration as predictors of positive sentinel lymph node in malignant melanoma patients, Melanoma Res, 14, 277, 10.1097/01.cmr.0000136712.82910.a1 Glass, 1993, Histopathologic study of recurrent Clark level II melanomas, Semin Surg Oncol, 9, 202, 10.1002/j.1098-2388.1993.tb00008.x Chang, 2003, Melanoma in the elderly patient, Arch Surg, 138, 1135, 10.1001/archsurg.138.10.1135 Chang, 2003, Thick melanoma in the elderly, Am Surg, 69, 988, 10.1177/000313480306901115 Grande Sarpa, 2006, Prognostic significance of extent of ulceration in primary cutaneous melanoma, Am J Surg Pathol, 30, 1396, 10.1097/01.pas.0000213262.61855.7d Schmid-Wendtner, 2001, Prognostic index for cutaneous melanoma: an analysis after follow-up of 2715 patients, Melanoma Res, 11, 619, 10.1097/00008390-200112000-00008 Azzola, 2003, Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center, Cancer, 97, 1488, 10.1002/cncr.11196 Barnhill, 2005, The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma, J Cutan Pathol, 32, 268, 10.1111/j.0303-6987.2005.00310.x Smolle, 1993, Tumor cell proliferation and motility estimates are prognostic factors in malignant melanoma, Anal Cell Pathol, 5, 113 Kashani-Sabet, 2002, Tumor vascularity in the prognostic assessment of primary cutaneous melanoma, J Clin Oncol, 20, 1826, 10.1200/JCO.2002.07.082 Fortes, 2006, Survival and prognostic variables of cutaneous melanoma observed between 1995 and 2000 at Istituto Dermopatico Dell’Immacolata (IDI-IRCCS), Rome, Italy, Eur J Cancer Prev, 15, 171, 10.1097/01.cej.0000178077.27748.fb Attis, 2007, Mitotic rate in melanoma: a reexamination, Am J Clin Pathol, 127, 380, 10.1309/LB7RTC61B7LC6HJ6 Kashani-Sabet, 2001, Vascular involvement in the prognosis of primary cutaneous melanoma, Arch Dermatol, 137, 1169, 10.1001/archderm.137.9.1169 Schmoeckel, 1978, Prognostic index in malignant melanoma, Arch Dermatol, 114, 871, 10.1001/archderm.114.6.871 Kopf, 1987, Prognostic index for malignant melanoma, Cancer, 59, 1236, 10.1002/1097-0142(19870315)59:6<1236::AID-CNCR2820590634>3.0.CO;2-I Oliveira Filho, 2003, Vertical growth phase and positive sentinel node in thin melanoma, Braz J Med Biol Res, 36, 347, 10.1590/S0100-879X2003000300009 Lefevre, 2003, Relevance of vertical growth pattern in thin level II cutaneous superficial spreading melanomas, Am J Surg Pathol, 27, 717, 10.1097/00000478-200306000-00002 Mansson-Brahme, 1994, Prognostic factors in thin cutaneous malignant melanoma, Cancer, 73, 2324, 10.1002/1097-0142(19940501)73:9<2324::AID-CNCR2820730914>3.0.CO;2-5 Paladugu, 1983, Biologic behavior of thin malignant melanomas with regressive changes, Arch Surg, 118, 41, 10.1001/archsurg.1983.01390010031008 Sondergaard, 1985, Partial regression in thin primary cutaneous malignant melanomas clinical stage I. A study of 486 cases, Virchows Arch A Pathol Anat Histopathol, 408, 241, 10.1007/BF00707986 Ronan, 1987, Thin malignant melanomas with regression and metastases, Arch Dermatol, 123, 1326, 10.1001/archderm.123.10.1326 Shaw, 1992, Cutaneous melanomas exhibiting unusual biologic behavior, World J Surg, 16, 196, 10.1007/BF02071521 Guitart, 2002, Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases, Arch Dermatol, 138, 603, 10.1001/archderm.138.5.603 Trau, 1983, Metastases of thin melanomas, Cancer, 51, 553, 10.1002/1097-0142(19830201)51:3<553::AID-CNCR2820510332>3.0.CO;2-T Kelly, 1985, Regression in malignant melanoma. A histologic feature without independent prognostic significance, Cancer, 56, 2287, 10.1002/1097-0142(19851101)56:9<2287::AID-CNCR2820560924>3.0.CO;2-Y Briggs, 1984, Experience of thin cutaneous melanomas (less than 0.76 mm and less than 0.85 mm thick) in a large plastic surgery unit: a 5 to 17 year follow-up, Br J Plast Surg, 37, 501, 10.1016/0007-1226(84)90139-5 Cooper, 1985, Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance, Arch Dermatol, 121, 1127, 10.1001/archderm.121.9.1127 Brogelli, 1992, The prognostic significance of histologic regression in cutaneous melanoma, Melanoma Res, 2, 87, 10.1097/00008390-199207000-00002 McCarthy, 1996, Cutaneous melanomas that defy conventional prognostic indicators, Semin Oncol, 23, 709 Clemente, 1996, Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma, Cancer, 77, 1303, 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5 Cecchi, 2007, Sentinel lymph node biopsy in patients with thin melanomas, J Dermatol, 34, 512, 10.1111/j.1346-8138.2007.00323.x Kaur, 2008, The correlation of regression in primary melanoma with sentinel lymph node status, J Clin Pathol, 61, 297, 10.1136/jcp.2007.049411 Massi, 1999, Thin cutaneous malignant melanomas (<or=1.5 mm): identification of risk factors indicative of progression, Cancer, 85, 1067, 10.1002/(SICI)1097-0142(19990301)85:5<1067::AID-CNCR9>3.0.CO;2-T Shaw, 1989, Thin regressing malignant melanoma: significance of concurrent regional lymph node metastases, Histopathology, 15, 257, 10.1111/j.1365-2559.1989.tb03076.x Barnhill, 1993, Regressing thin cutaneous malignant melanomas (<or=1.0 mm) are associated with angiogenesis, Am J Pathol, 143, 99 Taylor, 2007, Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma, J Clin Oncol, 25, 869, 10.1200/JCO.2006.08.9755 Day, 1982, A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models, Ann Surg, 195, 44, 10.1097/00000658-198201001-00007 Elder, 1985, The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51-3.99 mm), Cancer, 56, 413, 10.1002/1097-0142(19850715)56:2<413::AID-CNCR2820560234>3.0.CO;2-T Tuthill, 2002, Risk assessment in localized primary cutaneous melanoma: a Southwest Oncology Group study evaluating nine factors and a test of the Clark logistic regression prediction model, Am J Clin Pathol, 118, 504, 10.1309/WBF7-N8KH-71KT-RVQ9 Hakansson, 2001, Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes, Br J Cancer, 85, 1871, 10.1054/bjoc.2001.2169 Ladanyi, 2004, T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma, Clin Cancer Res, 10, 521, 10.1158/1078-0432.CCR-1161-03 Movassagh, 2004, Selective accumulation of mature DC-Lamp+dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma, Cancer Res, 64, 2192, 10.1158/0008-5472.CAN-03-2969 Ladanyi, 2007, Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor, Cancer Immunol Immunother, 56, 1459, 10.1007/s00262-007-0286-3 Spatz, 1998, Analysis of histopathological factors associated with prolonged survival of 10 years or more for patients with thick melanomas (>5 mm), Histopathology, 33, 406, 10.1046/j.1365-2559.1998.00523.x Anichini, 2004, The paradox of T-cell-mediated antitumor immunity in spite of poor clinical outcome in human melanoma, Cancer Immunol Immunother, 53, 855, 10.1007/s00262-004-0526-8 Marincola, 2003, Tumors as elusive targets of T-cell-based active immunotherapy, Trends Immunol, 24, 335, 10.1016/S1471-4906(03)00116-9 Dunn, 2002, Cancer immunoediting: from immunosurveillance to tumor escape, Nat Immunol, 3, 991, 10.1038/ni1102-991 Lassau, 2006, Prognostic value of angiogenesis evaluated with high-frequency and colour Doppler sonography for preoperative assessment of primary cutaneous melanomas: correlation with recurrence after a 5 year follow-up period, Cancer Imaging, 6, 24, 10.1102/1470-7330.2006.0009 Fallowfield, 1991, The vascularity of primary cutaneous melanoma, J Pathol, 164, 241, 10.1002/path.1711640309 Denekamp, 1993, Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy, Br J Radiol, 66, 181, 10.1259/0007-1285-66-783-181 Vlaykova, 1999, Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression, Melanoma Res, 9, 59, 10.1097/00008390-199902000-00008 Carlson, 2005, Molecular diagnostics in melanoma, J Am Acad Dermatol, 52, 743, 10.1016/j.jaad.2004.08.034 Barnhill, 1992, Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma, Lab Invest, 67, 331 Vlaykova, 1997, Vascularity and prognosis of metastatic melanoma, Int J Cancer, 74, 326, 10.1002/(SICI)1097-0215(19970620)74:3<326::AID-IJC16>3.0.CO;2-9 Srivastava, 1988, The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study, Am J Pathol, 133, 419 Depasquale, 2005, Microvessel density for melanoma prognosis, Histopathology, 47, 186, 10.1111/j.1365-2559.2005.02193.x Rongioletti, 1996, Tumor vascularity as a prognostic indicator in intermediate-thickness (0.76-4 mm) cutaneous melanoma. A quantitative assay, Am J Dermatopathol, 18, 474, 10.1097/00000372-199610000-00005 Neitzel, 1999, Angiogenesis correlates with metastasis in melanoma, Ann Surg Oncol, 6, 70, 10.1007/s10434-999-0070-z Erhard, 1997, Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis, Melanoma Res, 7, S19 Marcoval, 1997, Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase, J Cutan Pathol, 24, 212, 10.1111/j.1600-0560.1997.tb01583.x Straume, 1999, Angiogenesis is prognostically important in vertical growth phase melanomas, Int J Oncol, 15, 595 Straume, 2001, Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas, Am J Pathol, 159, 223, 10.1016/S0002-9440(10)61688-4 Carnochan, 1991, The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness, Br J Cancer, 64, 102, 10.1038/bjc.1991.250 Graham, 1994, Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas, Am J Pathol, 145, 510 Busam, 1995, Tumor vascularity is not a prognostic factor for malignant melanoma of the skin, Am J Pathol, 147, 1049 Ilmonen, 1999, Prognostic value of tumour vascularity in primary melanoma, Melanoma Res, 9, 273, 10.1097/00008390-199906000-00009 Balch, 2000, A new American Joint Committee on Cancer staging system for cutaneous melanoma, Cancer, 88, 1484, 10.1002/(SICI)1097-0142(20000315)88:6<1484::AID-CNCR29>3.0.CO;2-D Lugassy, 2007, Angiotropic melanoma and extravascular migratory metastasis: a review, Adv Anat Pathol, 14, 195, 10.1097/PAP.0b013e31805048d9 Barnhill, 2001, The biology of melanoma micrometastases, Recent Results Cancer Res, 158, 3, 10.1007/978-3-642-59537-0_1 Lugassy, 2000, Melanoma and extravascular migratory metastasis, J Cutan Pathol, 27, 481, 10.1034/j.1600-0560.2000.027009481.x Lugassy, 1999, Ultrastructural and immunohistochemical studies of the periendothelial matrix in human melanoma: evidence for an amorphous matrix containing laminin, J Cutan Pathol, 26, 78, 10.1111/j.1600-0560.1999.tb01806.x Lugassy, 1997, Angio-tumoral complex in human malignant melanoma characterised by free laminin: ultrastructural and immunohistochemical observations, J Submicrosc Cytol Pathol, 29, 19 Lugassy, 1999, Tumor microvessels in melanoma express the beta-2 chain of laminin. Implications for melanoma metastasis, J Cutan Pathol, 26, 222, 10.1111/j.1600-0560.1999.tb01834.x Lugassy, 2002, Human melanoma cell migration along capillary-like structures in vitro: a new dynamic model for studying extravascular migratory metastasis, J Invest Dermatol, 119, 703, 10.1046/j.1523-1747.2002.01857.x Barnhill, 2004, Angiotropic malignant melanoma and extravascular migratory metastasis: description of 36 cases with emphasis on a new mechanism of tumour spread, Pathology, 36, 485, 10.1080/00313020412331282708 Handley, 1907, The pathology of melanotic growths in relation to their operative treatment, Lancet, 169, 996, 10.1016/S0140-6736(01)54641-3 Gerami, 2006, Angiotropism in epidermotropic metastatic melanoma: another clue to the diagnosis, Am J Dermatopathol, 28, 429, 10.1097/01.dad.0000204761.40199.3f Johnson, 2001, Ultra-late erysipeloid angiotropic metastatic malignant melanoma, Int J Dermatol, 40, 446, 10.1046/j.1365-4362.2001.01214.x Shea, 1995, Angiotropic metastatic malignant melanoma, Am J Dermatopathol, 17, 58, 10.1097/00000372-199502000-00011 Moreno, 1992, Angiotropic malignant melanoma. Report of two cases, J Cutan Pathol, 19, 325, 10.1111/j.1600-0560.1992.tb01369.x Barnhill, 2002, Angiotropism in cutaneous melanoma: a prognostic factor strongly predicting risk for metastasis, J Invest Dermatol, 119, 705, 10.1046/j.1523-1747.2002.01871.x Lugassy, 2006, Angiotropism of human melanoma: studies involving in transit and other cutaneous metastases and the chicken chorioallantoic membrane: implications for extravascular melanoma invasion and metastasis, Am J Dermatopathol, 28, 187, 10.1097/00000372-200606000-00001 Setala, 1996, Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration, Br J Cancer, 74, 766, 10.1038/bjc.1996.434 Pinder, 1994, Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up, Histopathology, 24, 41, 10.1111/j.1365-2559.1994.tb01269.x Sondergaard, 1985, Therapeutic and clinico-pathological factors in the survival of 1,469 patients with primary cutaneous malignant melanoma in clinical stage I. A multivariate regression analysis, Virchows Arch A Pathol Anat Histopathol, 408, 249, 10.1007/BF00707987 Bachaud, 1992, Stage I cutaneous malignant melanoma: risk factors of loco-regional recurrence after wide local excision and clinical perspectives, Eur J Surg Oncol, 18, 442 Gamel, 1993, Skin melanoma. Cured fraction and survival time as functions of thickness, site, histologic type, age, and sex, Cancer, 72, 1219, 10.1002/1097-0142(19930815)72:4<1219::AID-CNCR2820720414>3.0.CO;2-0 MacKie, 1995, Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86, and their subsequent validation, Br J Cancer, 71, 173, 10.1038/bjc.1995.35 Thorn, 1994, Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden, J Natl Cancer Inst, 86, 761, 10.1093/jnci/86.10.761 Lugassy, 1997, Is the angio-tumoral complex in human malignant melanoma a marker of non-hematogenous migration? [abstract], Melanoma Res, 7, S95, 10.1097/00008390-199706001-00331 Barnhill, 2000, Angiotropic melanoma: report of seven additional cases. [abstract], J Cutan Pathol, 27, 548 Schmoeckel, 1983, Low-and high-risk malignant melanoma-I. Evaluation of clinical and histological prognosticators in 585 cases, Eur J Cancer Clin Oncol, 19, 227, 10.1016/0277-5379(83)90421-2 Arrington, 1977, Plantar lentiginous melanoma: a distinctive variant of human cutaneous malignant melanoma, Am J Surg Pathol, 1, 131, 10.1097/00000478-197706000-00004 MacKie, 2000, Malignant melanoma: clinical variants and prognostic indicators, Clin Exp Dermatol, 25, 471, 10.1046/j.1365-2230.2000.00692.x Swetter SM. Dermatological perspectives of malignant melanoma. Surg Clin North Am 2003;83:77-95, vi. Weyers, 1999, Classification of cutaneous malignant melanoma: a reassessment of histopathologic criteria for the distinction of different types, Cancer, 86, 288, 10.1002/(SICI)1097-0142(19990715)86:2<288::AID-CNCR13>3.0.CO;2-S Hacene, 1983, Prognostic index for clinical Stage I cutaneous malignant melanoma, Cancer Res, 43, 2991 Ringborg, 1993, Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group, Cancer, 71, 751, 10.1002/1097-0142(19930201)71:3<751::AID-CNCR2820710317>3.0.CO;2-9 Crocetti, 2006, Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study, Melanoma Res, 16, 429, 10.1097/01.cmr.0000222602.80803.e1 Golger, 2007, Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study, Arch Otolaryngol Head Neck Surg, 133, 442, 10.1001/archotol.133.5.442 Kuno, 1996, Clinical and pathological features of cutaneous malignant melanoma: a retrospective analysis of 124 Japanese patients, Jpn J Clin Oncol, 26, 144, 10.1093/oxfordjournals.jjco.a023198 Giuliano, 1982, Melanoma from unknown primary site and amelanotic melanoma, Semin Oncol, 9, 442 McGovern, 1981, Cell type and pigment content as prognostic indicators in cutaneous malignant melanoma, 327 Schuchter, 1996, A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group, Ann Intern Med, 125, 369, 10.7326/0003-4819-125-5-199609010-00003 Koch, 2000, Amelanotic melanoma: the great masquerader, J Am Acad Dermatol, 42, 731, 10.1067/mjd.2000.103981 Leon, 1991, The prognostic implications of microscopic satellites in patients with clinical stage I melanoma, Arch Surg, 126, 1461, 10.1001/archsurg.1991.01410360031006 Pol-Rodriquez, 2007, Influence of age on survival in childhood spitzoid melanomas, Cancer, 109, 1579, 10.1002/cncr.22584 Fabrizi, 2001, Spitzoid malignant melanoma in teenagers: an entity with no better prognosis than that of other forms of melanoma, Histopathology, 38, 448, 10.1046/j.1365-2559.2001.01102.x Magro, 2006, Unusual variants of malignant melanoma, Mod Pathol, 19, S41, 10.1038/modpathol.3800516 Won, 1994, Signet-ring cell melanoma: poor prognostic factor?, Br J Dermatol, 131, 135, 10.1111/j.1365-2133.1994.tb08474.x Breier, 1999, Primary invasive signet-ring cell melanoma, J Cutan Pathol, 26, 533, 10.1111/j.1600-0560.1999.tb01802.x Rutten, 2003, Primary cutaneous signet-ring cell melanoma: a clinico-pathologic and immunohistochemical study of two cases, Am J Dermatopathol, 25, 418, 10.1097/00000372-200310000-00007 Podnos, 2002, Minimal deviation melanoma, Cancer Treat Rev, 28, 219, 10.1016/S0305-7372(02)00035-X Phillips, 1986, The spectrum of minimal deviation melanoma: a clinicopathologic study of 21 cases, Hum Pathol, 17, 796, 10.1016/S0046-8177(86)80199-X Schmoeckel, 1985, Nevoid malignant melanoma, Arch Dermatol Res, 277, 362, 10.1007/BF00509234 Zembowicz, 2001, Morphological analysis of nevoid melanoma: a study of 20 cases with a review of the literature, Am J Dermatopathol, 23, 167, 10.1097/00000372-200106000-00001 Busam, 2004, Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors, Am J Surg Pathol, 28, 1518, 10.1097/01.pas.0000141391.91677.a4 Busam, 2005, Cutaneous desmoplastic melanoma, Adv Anat Pathol, 12, 92, 10.1097/01.pap.0000155071.86944.a6 Gyorki, 2003, Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma, Ann Surg Oncol, 10, 403, 10.1245/ASO.2003.04.003 Payne, 2001, Desmoplastic melanoma, Am Surg, 67, 1004, 10.1177/000313480106701020 Jaroszewski, 2001, The clinical behavior of desmoplastic melanoma, Am J Surg, 182, 590, 10.1016/S0002-9610(01)00819-4 Quinn, 1998, Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients, Cancer, 83, 1128, 10.1002/(SICI)1097-0142(19980915)83:6<1128::AID-CNCR11>3.0.CO;2-7 Carlson, 1995, Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases, Cancer, 75, 478, 10.1002/1097-0142(19950115)75:2<478::AID-CNCR2820750211>3.0.CO;2-O Skelton, 1995, Desmoplastic malignant melanoma, J Am Acad Dermatol, 32, 717, 10.1016/0190-9622(95)91448-X Conley, 1971, Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma), Cancer, 28, 914, 10.1002/1097-0142(1971)28:4<914::AID-CNCR2820280415>3.0.CO;2-E Egbert, 1988, Desmoplastic malignant melanoma. A clinicohistopathologic study of 25 cases, Cancer, 62, 2033, 10.1002/1097-0142(19881101)62:9<2033::AID-CNCR2820620927>3.0.CO;2-E Baer, 1995, Desmoplasia and neurotropism. Prognostic variables in patients with stage I melanoma, Cancer, 76, 2242, 10.1002/1097-0142(19951201)76:11<2242::AID-CNCR2820761110>3.0.CO;2-I Day, 1981, Malignant melanoma patients with positive nodes and relatively good prognoses: microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes, Cancer, 47, 955, 10.1002/1097-0142(19810301)47:5<955::AID-CNCR2820470523>3.0.CO;2-1 Balch, 1979, A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma, Surgery, 86, 343 Hawkins, 2005, Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma, Ann Surg Oncol, 12, 207, 10.1245/ASO.2005.03.022 Su, 2004, Desmoplastic and neurotropic melanoma, Cancer, 100, 598, 10.1002/cncr.11947 Thelmo, 2001, Evaluation of sentinel lymph node status in spindle cell melanomas, J Am Acad Dermatol, 44, 451, 10.1067/mjd.2001.110881 Cummins, 2007, Lymph node biopsy results for desmoplastic malignant melanoma, Cutis, 79, 390 Reed, 1988, Minimal deviation melanoma, 110 Livestro, 2005, Biology of desmoplastic melanoma: a case-control comparison with other melanomas, J Clin Oncol, 23, 6739, 10.1200/JCO.2005.04.515 Shaw, 2006, Survival in patients with desmoplastic melanoma, J Clin Oncol, 24, e12, 10.1200/JCO.2005.04.9395 Reed, 1979, Neurotropic melanoma. A variant of desmoplastic melanoma, Am J Surg Pathol, 3, 301, 10.1097/00000478-197908000-00002 Newlin, 2005, Neurotropic melanoma of the head and neck with clinical perineural invasion, Am J Clin Oncol, 28, 399, 10.1097/01.coc.0000144853.76112.3d Anderson, 2002, Desmoplastic neurotropic melanoma of the head and neck: the role of radiation therapy, Head Neck, 24, 1068, 10.1002/hed.10141 Madrigal, 1998, De novo desmoplastic neurotropic melanoma of the lower lip: a neoplasm with ominous behavior, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 86, 452, 10.1016/S1079-2104(98)90372-9 Lin, 2005, Neurotropic melanoma invading the inferior alveolar nerve, J Am Acad Dermatol, 53, S120, 10.1016/j.jaad.2004.11.057 Fabre, 2003, [Trigeminal neuralgia presenting as a deep recurrent desmoplastic neurotropic melanoma of a lentigo maligna]. French, Ann Dermatol Venereol, 130, 1044 Byrne, 1995, Neurotropic desmoplastic melanoma: a rare vulvar malignancy, Gynecol Oncol, 56, 289, 10.1006/gyno.1995.1048 Barnhill, 1995, Neurotropic melanoma with prominent melanization, J Cutan Pathol, 22, 450, 10.1111/j.1600-0560.1995.tb00762.x Larsen, 1978, A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 2. The relation of cell type, pigmentation, atypia and mitotic count to histological type and prognosis, Acta Pathol Microbiol Scand [A], 86A, 513 Weatherhead, 2007, Melanomas arising from naevi and de novo melanomas-does origin matter?, Br J Dermatol, 156, 72, 10.1111/j.1365-2133.2006.07570.x Friedman, 1983, Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi, Arch Dermatol, 119, 455, 10.1001/archderm.119.6.455 Drunkenmolle, 2005, Paratumoral epidermal hyperplasia: a novel prognostic factor in thick primary melanoma of the skin?, Am J Dermatopathol, 27, 482, 10.1097/01.dad.0000181106.01168.58 Kaddu, 2002, Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis, Melanoma Res, 12, 271, 10.1097/00008390-200206000-00011 Mott, 2002, Melanoma associated with pseudoepitheliomatous hyperplasia: a case series and investigation into the role of epidermal growth factor receptor, J Cutan Pathol, 29, 490, 10.1034/j.1600-0560.2002.290807.x Hanly, 2000, Cutaneous malignant melanoma associated with extensive pseudoepitheliomatous hyperplasia. Report of a case and discussion of the origin of pseudoepitheliomatous hyperplasia, J Cutan Pathol, 27, 153, 10.1034/j.1600-0560.2000.027003153.x Reis-Filho, 2001, Pseudoepitheliomatous hyperplasia in cutaneous malignant melanoma: a rare and misleading feature, J Cutan Pathol, 28, 496, 10.1034/j.1600-0560.2001.028009496.x Nakayama, 2001, Molecular clonality of in-transit melanoma metastasis, Am J Pathol, 158, 1371, 10.1016/S0002-9440(10)64088-6 Wong, 1990, Natural history and selective management of in transit melanoma, J Surg Oncol, 44, 146, 10.1002/jso.2930440305 Shaikh, 2005, The role of microsatellites as a prognostic factor in primary malignant melanoma, Arch Dermatol, 141, 739, 10.1001/archderm.141.6.739 Day, 1981, Malignant melanoma. Prognostic significance of “microscopic satellites” in the reticular dermis and subcutaneous fat, Ann Surg, 194, 108, 10.1097/00000658-198107000-00019 Harrist, 1984, “Microscopic satellites” are more highly associated with regional lymph node metastases than is primary melanoma thickness, Cancer, 53, 2183, 10.1002/1097-0142(19840515)53:10<2183::AID-CNCR2820531029>3.0.CO;2-9 Singletary, 1988, Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanoma, Cancer, 61, 1437, 10.1002/1097-0142(19880401)61:7<1437::AID-CNCR2820610726>3.0.CO;2-Z Cascinelli, 1986, Regional non-nodal metastases of cutaneous melanoma, Eur J Surg Oncol, 12, 175 Sutherland, 1987, Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion, Surg Gynecol Obstet, 164, 111